Between July 27 and August 1, 2016, FDA announced the fiscal year 2017 ("FY2017") user fee raters for generic drugs, animal drugs, animal generic drugs, biosimilars, prescription drugs, medical devices, and human drug compounding outsourcing facilities. Click here to view a chart summarizing the fees and the percent change over the previous year. The fee rates are effective October 1, 2016, and will remain in effect through September 30, 2017.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
